Clinical Trial Update: Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the long-term safety, tolerability, and efficacy of adding perampanel (E2007) to levodopa in Parkinson's disease with motor fluctuation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Perampanel (Fycompa) (perampanel)

Snippet

Sponsor: Eisai Limited | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2012-11-22